Valtecne (VLT) Investor presentation summary

Group structure and business overview

• Group ownership includes significant stakes by Mainetti family and KPM S.r.l., with 18.2% free float and 40% held by Utilità Group.

• Utilità, acquired at 60%, is integrated into the group, focusing on hi-tech for humans since 1992.

Financial performance highlights

• FY 2025 revenues reached €35.7M, down 3.3%, while value of production rose 2.0% to €37.3M.

• Medical devices now represent 73% of total revenues, with industrial segments still declining.

• Adjusted EBITDA was €9.7M (26% margin), down 4.4% from prior year; reported EBITDA at €8.1M.

• Net profit dropped 31% to €3.3M, mainly due to Utilità goodwill amortization.

• Net financial position improved to €1.8M, reflecting strong cash generation despite €0.6M in dividends.

Segment analysis and trends

• Medical line revenues slightly decreased by 2.1% due to tough dental segment comparison and VMI dynamics.

• Industrial segment decline moderated by aerospace growth; medical share of revenues increased to 73.3%.

• Standalone medical business grew, offsetting industrial decline; medical now 75% of revenues.

• Value of production for medical line up 16.3%, driving overall VoP growth.